The Identification of Blood Biomarkers of Chronic Neuropathic Pain by Comparative Transcriptomics
NeuroMolecular Medicine · 2022-09 · 24 (3) · 320-338
DOI: 10.1007/s12017-021-08694-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroMolecular Medicine, online erschienen am 05.11.2021. Verfasst von Barira Islam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Biomarker Research, University of Huddersfield, Huddersfield, HD1 3DH, UK. Hauptthemen laut MEDLINE: Biomarkers, Chronic Pain, Neuralgia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Pain Society, Pain Relief Foundation, Centre for Biomarker Research.
Abstract (Originalsprache)
In this study, we recruited 50 chronic pain (neuropathic and nociceptive) and 43 pain-free controls to identify specific blood biomarkers of chronic neuropathic pain (CNP). Affymetrix microarray was carried out on a subset of samples selected 10 CNP and 10 pain-free control participants. The most significant genes were cross-validated using the entire dataset by quantitative real-time PCR (qRT-PCR). In comparative analysis of controls and CNP patients, WLS ( P = 4.80 × 10 –7 ), CHPT1 ( P = 7.74 × 10 –7 ) and CASP5 ( P = 2.30 × 10 –5 ) were highly significant, whilst FGFBP2 ( P = 0.00162), STAT1 ( P = 0.00223), FCRL6 ( P = 0.00335), MYC ( P = 0.00335), XCL2 ( P = 0.0144) and GZMA ( P = 0.0168) were significant in all CNP patients. A three-arm comparative analysis was also carried out with control as the reference group and CNP samples differentiated into two groups of high and low S-LANSS score using a cut-off of 12. STAT1 , XCL2 and GZMA were not significant but KIR3DL2 ( P = 0.00838), SH2D1B ( P = 0.00295) and CXCR31 ( P = 0.0136) were significant in CNP high S-LANSS group (S-LANSS score > 12), along with WLS (P = 8.40 × 10 –5 ), CHPT1 ( P = 7.89 × 10 –4 ) , CASP5 ( P = 0.00393) , FGFBP2 ( P = 8.70 × 10 –4 ) and FCRL6 ( P = 0.00199), suggesting involvement of immune pathways in CNP mechanisms. None of the genes was significant in CNP samples with low (< 12) S-LANSS score. The area under the receiver operating characteristic (AUROC) analysis showed that combination of MYC , STAT1 , TLR4 , CASP5 and WLS gene expression could be potentially used as a biomarker signature of CNP (AUROC − 0.852, (0.773, 0.931 95% CI)).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Biomarker Research, University of Huddersfield, Huddersfield, HD1 3DH, UK.
- School of Applied Sciences, University of Huddersfield, Huddersfield, HD1 3DH, UK.
- School of Human and Health Sciences, University of Huddersfield, Huddersfield, HD1 3DH, UK.
- St. James University Hospital, Leeds, LS9 7TF, UK.
- Medical School, University of Cyprus, Nicosia, Cyprus.
- Centre for Pain Research, School of Clinical and Applied Sciences, Leeds Beckett University, Leeds, LS1 3HE, UK.
ORCID-Profile: Patrick C McHugh
Förderung
- British Pain Society
- Pain Relief Foundation
- Centre for Biomarker Research
Zitieren
APA
Islam, B., Stephenson, J., Young, B., Manca, M., Buckley, D. A., Radford, H., Zis, P., Johnson, M. I., Finn, D. P., & McHugh, P. C. (2022). The Identification of Blood Biomarkers of Chronic Neuropathic Pain by Comparative Transcriptomics. NeuroMolecular Medicine, 24(3), 320-338. https://doi.org/10.1007/s12017-021-08694-8
Vancouver
Islam B, Stephenson J, Young B, Manca M, Buckley DA, Radford H, et al. The Identification of Blood Biomarkers of Chronic Neuropathic Pain by Comparative Transcriptomics. NeuroMolecular Medicine. 2022;24(3):320-338. doi:10.1007/s12017-021-08694-8
BibTeX
@article{Islam2022,
author = {Islam, Barira and Stephenson, John and Young, Bethan and Manca, Maurizio and Buckley, David A and Radford, Helen and Zis, Panagiotis and Johnson, Mark I and Finn, David P and McHugh, Patrick C},
title = {The Identification of Blood Biomarkers of Chronic Neuropathic Pain by Comparative Transcriptomics},
journal = {NeuroMolecular Medicine},
year = {2022},
volume = {24},
number = {3},
pages = {320--338},
doi = {10.1007/s12017-021-08694-8}
}
EUVIMED